An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism (Q40548373)

21 September 2017

title

An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism (English)

1 reference

21 September 2017

1 reference

3

Akseli Hemminki

1 reference

21 September 2017

6

David T Curiel

1 reference

21 September 2017

4

Gene P Siegal

1 reference

21 September 2017

Joel N Glasgow

1

1 reference

21 September 2017

Eric J Kremer

series ordinal

2

1 reference

21 September 2017

Joanne T Douglas

series ordinal

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

324

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

103-116

1 reference

An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Receptors mediating adenovirus attachment and internalization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Trafficking and propagation of canine adenovirus vectors lacking a known integrin-interacting motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Structural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Determinants of ligand binding specificity of the alpha(1)beta(1) and alpha(2)beta(1) integrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Improved adenovirus vectors for infection of cardiovascular tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Adenoviruses in oncology: a viable option?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Biology of ovine adenovirus infection of nonpermissive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Advances in the development of non-human viral DNA-vectors for gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Construction, Rescue, and Characterization of Vectors Derived from Ovine Atadenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Mouse adenovirus (MAV-1) expression in primary human endothelial cells and generation of a full-length infectious plasmid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Sequence analysis of the canine adenovirus 2 fiber-encoding gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Novel human gene transfer vectors: evaluation of wild-type and recombinant animal adenoviruses in human-derived cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Characterization of cis-acting sequences involved in canine adenovirus packaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

A triple beta-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

7 January 2021

Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

7 January 2021

Abortive infection of human cell cultures by a canine adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

7 January 2021

Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

7 January 2021

Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

7 January 2021

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.028

7 January 2021

10.1016/J.VIROL.2004.03.028

Identifiers

DOI

1 reference

21 September 2017

1 reference